Medical company focused on improving the efficacy;safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias
Endosense has raised €59M across 3 funding rounds from 3 investors, most recently a Series C round in Mar 2013. Based in Geneva, Switzerland; founded 2003; active in Healthtech. Acquired by St. Jude Medical in 2010. Data as of 7 Aug 2026.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-03-01 | Series C | €3.3M | — | View deal → |
| 2012-11-01 | Series C | €31M | GIMV,Ysios Capital |
| View deal → |
| 2009-10-01 | Series B | €25M | GIMV,NeoMed,Ysios Capital | View deal → |
